NCT05795816View on ClinicalTrials.gov

Effectiveness of Testofen Compared to Placebo on Long COVID Symptoms

PHASE3CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

October 25, 2023

Primary Completion Date

January 30, 2025

Study Completion Date

January 31, 2025

Conditions
Long Covid19
Interventions
DRUG

Testofen

Twice daily dose of 1 capsule (300mg per capsule Testofen)

DRUG

Microcrystalline cellulose

Twice daily dose of 1 capsule

Trial Locations (1)

4006

RDC Clinical Pty Ltd, Brisbane

All Listed Sponsors
lead

RDC Clinical Pty Ltd

INDUSTRY

NCT05795816 - Effectiveness of Testofen Compared to Placebo on Long COVID Symptoms | Biotech Hunter | Biotech Hunter